Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bruker (BRKR) Equity Average (2016 - 2025)

Historic Equity Average for Bruker (BRKR) over the last 15 years, with Q3 2025 value amounting to $2.1 billion.

  • Bruker's Equity Average rose 1753.26% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 1753.26%. This contributed to the annual value of $1.6 billion for FY2024, which is 2663.97% up from last year.
  • Per Bruker's latest filing, its Equity Average stood at $2.1 billion for Q3 2025, which was up 1753.26% from $1.8 billion recorded in Q2 2025.
  • Bruker's Equity Average's 5-year high stood at $2.1 billion during Q3 2025, with a 5-year trough of $966.2 million in Q3 2022.
  • In the last 5 years, Bruker's Equity Average had a median value of $1.2 billion in 2023 and averaged $1.3 billion.
  • As far as peak fluctuations go, Bruker's Equity Average tumbled by 819.95% in 2022, and later soared by 4658.57% in 2024.
  • Quarter analysis of 5 years shows Bruker's Equity Average stood at $1.1 billion in 2021, then fell by 4.62% to $1.0 billion in 2022, then increased by 26.43% to $1.3 billion in 2023, then skyrocketed by 38.16% to $1.8 billion in 2024, then increased by 17.85% to $2.1 billion in 2025.
  • Its Equity Average was $2.1 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.8 billion in Q1 2025.